Range Low Price High Price Comment
30 days $0.633 $1.34 Wednesday, 1st May 2024 VXRT stock ended at $0.701. This is 1.97% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.29% from a day low at $0.700 to a day high of $0.730.
90 days $0.633 $1.54
52 weeks $0.530 $1.59

Historical Vaxart prices

Date Open High Low Close Volume
Jan 12, 2024 $0.570 $0.580 $0.550 $0.560 463 688
Jan 11, 2024 $0.590 $0.600 $0.555 $0.577 622 332
Jan 10, 2024 $0.611 $0.611 $0.571 $0.587 770 429
Jan 09, 2024 $0.560 $0.610 $0.560 $0.600 870 727
Jan 08, 2024 $0.553 $0.572 $0.553 $0.571 425 155
Jan 05, 2024 $0.566 $0.590 $0.560 $0.573 485 777
Jan 04, 2024 $0.564 $0.585 $0.560 $0.578 433 777
Jan 03, 2024 $0.609 $0.610 $0.555 $0.564 1 237 083
Jan 02, 2024 $0.578 $0.639 $0.550 $0.609 1 520 184
Dec 29, 2023 $0.570 $0.585 $0.530 $0.573 1 458 312
Dec 28, 2023 $0.587 $0.600 $0.565 $0.570 1 233 723
Dec 27, 2023 $0.600 $0.610 $0.581 $0.600 852 319
Dec 26, 2023 $0.595 $0.620 $0.590 $0.600 729 959
Dec 22, 2023 $0.582 $0.607 $0.560 $0.585 1 098 749
Dec 21, 2023 $0.610 $0.620 $0.580 $0.600 941 939
Dec 20, 2023 $0.600 $0.620 $0.590 $0.603 846 366
Dec 19, 2023 $0.625 $0.630 $0.590 $0.613 1 612 831
Dec 18, 2023 $0.641 $0.650 $0.620 $0.623 533 538
Dec 15, 2023 $0.663 $0.680 $0.633 $0.633 770 847
Dec 14, 2023 $0.664 $0.690 $0.660 $0.670 739 550
Dec 13, 2023 $0.678 $0.686 $0.650 $0.680 521 246
Dec 12, 2023 $0.670 $0.686 $0.661 $0.664 484 793
Dec 11, 2023 $0.700 $0.710 $0.685 $0.687 351 542
Dec 08, 2023 $0.690 $0.708 $0.682 $0.708 448 364
Dec 07, 2023 $0.690 $0.710 $0.690 $0.698 305 797
Click to get the best stock tips daily for free!

About Vaxart

Vaxart Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the t... VXRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT